NASDAQ$ALHC

Alignment Healthcare Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Reported strong health plan membership growth and margin results.

Alignment Healthcare reported strong health plan membership growth and margin results for the second quarter of 2024. The company is at an inflection point on both growth and profitability and is positioning itself for another robust year in 2025.

  • Exceptional health plan membership growth.
  • Strong margin results in the second quarter.
  • Scale added year-to-date.
  • Strong execution on margin objectives.

Headline financials

Total Revenue

$681M

Previous: $462M+47.3%
EPS (adj)

-$0.13

Previous: -$0.15+13.3%
Capital Expenditures

-$22.9M

Previous: $8.56M-367.0%
Free Cash Flow

-$46.9M

Previous: -$28.5M-64.6%
Net Income

-$24M

Previous: -$28.5M+15.7%
Operating Income

-$18.4M

Previous: -$23.7M+22.3%
Gross Profit

$681M

Previous: $462M+47.3%
Cash & Equivalents

$339M

Previous: $395M-14.2%
Total Assets

$716M

Previous: $784M-8.6%
Stock-Based Comp

$16.8M

Previous: $15.6M+7.3%

Revenue & EPS history

Alignment Healthcare · Revenue · Quarterly

$681M

Q2 2024+47.3%vs Q2 2023
Beat estimate in 15 of 15 quarters(100%)
ActualEstimate

Revenue by segment

Alignment Healthcare · $265M total across 2 segments · Q1 2021

  • Earned premiums
    $265M+18.0%
  • Other revenue
    $82K

Forward guidance

The release contains forward-looking statements regarding the company's future growth and financial outlook for the third quarter ending September 30, 2024 and year ending December 31, 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+1.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+2.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+27.0%

Q1 2024

Best reaction

-16.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-15.7%-29.5%
Q4 2025-5.8%-7.5%-18.6%
Q3 2025-1.9%-0.4%+12.2%
Q1 2025-7.7%-7.5%-8.3%
Q4 2024+16.5%+17.4%+35.9%
Q3 2024+1.6%+12.2%+11.2%
Q2 2024+2.3%+4.9%+3.1%
Q1 2024+27.0%+31.6%+51.0%
Q4 2023-8.9%-9.2%-20.1%
Q3 2023-9.6%-7.2%+10.5%
Q2 2023+7.5%+10.5%-4.2%
Q1 2023+3.5%+11.3%-5.1%
Q4 2022-16.4%-20.9%-35.2%
Q3 2022-3.1%-3.3%-2.7%
Q2 2022+10.4%+4.3%-8.7%
Q1 2022-7.0%-18.8%+6.8%
Q4 2021+10.7%+8.0%+39.7%
Q3 2021+10.6%+6.1%-26.7%
Q2 2021-8.5%-4.8%-11.2%
Q1 2021+6.8%+13.3%+27.6%
Q4 2020+6.8%+13.3%+27.6%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro